- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: Benicar® | CS-866 | Olmetec®
olmesartan is an approved drug (FDA (2002))
Compound class: Synthetic organic
Comment: Marketed formulations may contain olmesartan medoxomil (PubChem CID 130881).
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
View more information in the IUPHAR Pharmacology Education Project: olmesartan
1. Koike H, Sada T, Mizuno M. (2001)
In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist.
J Hypertens Suppl, 19 (1): S3-14. [PMID:11451212]